An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Julien Péron; Pascal Roy; T. Conroy; F. Desseigne; M. Ychou; S. Gourgou-Bourgade; T. Stanbury; L. Roche; B. Ozenne; M. Buyse

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Julien Péron ¹ Pascal Roy ¹ T. Conroy F. Desseigne M. Ychou S. Gourgou-Bourgade T. Stanbury L. Roche ² B. Ozenne ¹ M. Buyse

1 Biostatistiques santé

Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]

2 LBBE - Laboratoire de Biométrie et Biologie Evolutive - UMR 5558

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02053624
Contributor : Lauriane Pillet <>
Submitted on : Friday, March 1, 2019 - 2:33:31 PM
Last modification on : Friday, June 7, 2019 - 6:15:40 PM

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Links full text

Identifiers

Collections

Citation

Export

Metrics

15

Contact

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

15

Contact